Lipocine to present at the raymond james human health innovation conference

Salt lake city, june 16, 2021 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the company will present at the raymond james human health innovation conference. the conference will be held virtually.

LPCN Ratings Summary

LPCN Quant Ranking